BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cui J, Yan W, Xu S, Wang Q, Zhang W, Liu W, Ni A. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients. PLoS One 2018;13:e0193171. [PMID: 29494658 DOI: 10.1371/journal.pone.0193171] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Yang Y, Zhu Y. A combined antibody and DNA assay for EBV infection in children. Front Pediatr 2022;10:989193. [DOI: 10.3389/fped.2022.989193] [Reference Citation Analysis]
2 Vahabi M, Ghazanfari T, Sepehrnia S. Molecular Mimicry, Hyperactive Immune System, And SARS-COV-2 Are Three Prerequisites of the Autoimmune Disease Triangle Following COVID-19 Infection. International Immunopharmacology 2022. [DOI: 10.1016/j.intimp.2022.109183] [Reference Citation Analysis]
3 Zhang WT, Zhu GL, Xu WQ, Zhang W, Wang HZ, Wang YB, Li YX. Association of PD-1/PD-L1 expression and Epstein--Barr virus infection in patients with invasive breast cancer. Diagn Pathol 2022;17:61. [PMID: 35842661 DOI: 10.1186/s13000-022-01234-3] [Reference Citation Analysis]
4 Laurynenka V, Ding L, Kaufman KM, James JA, Harley JB. A High Prevalence of Anti-EBNA1 Heteroantibodies in Systemic Lupus Erythematosus (SLE) Supports Anti-EBNA1 as an Origin for SLE Autoantibodies. Front Immunol 2022;13:830993. [PMID: 35251022 DOI: 10.3389/fimmu.2022.830993] [Reference Citation Analysis]
5 Iwata S, Tanaka Y. Association of Viral Infection With the Development and Pathogenesis of Systemic Lupus Erythematosus. Front Med 2022;9:849120. [DOI: 10.3389/fmed.2022.849120] [Reference Citation Analysis]
6 Pereira LMS, França EDS, Costa IB, Lima IT, Freire ABC, Ramos FLDP, Monteiro TAF, Macedo O, Sousa RCM, Freitas FB, Brasil Costa I, Vallinoto ACR. Epstein–Barr Virus (EBV) Genotypes Associated with the Immunopathological Profile of People Living with HIV-1: Immunological Aspects of Primary EBV Infection. Viruses 2022;14:168. [DOI: 10.3390/v14020168] [Reference Citation Analysis]
7 Pereira LMS, Dos Santos França E, Costa IB, Lima IT, Freire ABC, de Paula Ramos FL, Monteiro TAF, Macedo O, Sousa RCM, Freitas FB, Costa IB, Vallinoto ACR. Epidemiological risk factors associated with primary infection by Epstein-Barr virus in HIV-1-positive subjects in the Brazilian Amazon region. Sci Rep 2021;11:18476. [PMID: 34531433 DOI: 10.1038/s41598-021-97707-4] [Reference Citation Analysis]
8 Naughton P, Healy M, Enright F, Lucey B. Infectious Mononucleosis: diagnosis and clinical interpretation. Br J Biomed Sci 2021;78:107-16. [PMID: 33721513 DOI: 10.1080/09674845.2021.1903683] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Shi T, Huang L, Chen Z, Tian J. Characteristics of primary Epstein-Barr virus infection disease spectrum and its reactivation in children, in Suzhou, China. J Med Virol 2021;93:5048-57. [PMID: 33719067 DOI: 10.1002/jmv.26941] [Reference Citation Analysis]
10 Quaglia M, Merlotti G, De Andrea M, Borgogna C, Cantaluppi V. Viral Infections and Systemic Lupus Erythematosus: New Players in an Old Story. Viruses 2021;13:277. [PMID: 33670195 DOI: 10.3390/v13020277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
11 Zhao Y, Wang Y, Liu H, Ding K, Liu C, Yu H, Shao Z, Fu R. Effects of Epstein-Barr Virus Infection on CD19+ B Lymphocytes in Patients with Immunorelated Pancytopenia. J Immunol Res 2020;2020:4098235. [PMID: 32149157 DOI: 10.1155/2020/4098235] [Reference Citation Analysis]
12 Shi J, Ma W, Li W. Epidemiologic features of children with Epstein-Barr virus associated diseases in Hangzhou, China. J Med Virol 2020;92:1277-82. [PMID: 31750545 DOI: 10.1002/jmv.25633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Illescas-Montes R, Corona-Castro CC, Melguizo-Rodríguez L, Ruiz C, Costela-Ruiz VJ. Infectious processes and systemic lupus erythematosus. Immunology 2019;158:153-60. [PMID: 31386190 DOI: 10.1111/imm.13103] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
14 Cui J, Yan W, Xie H, Xu S, Wang Q, Zhang W, Ni A. Cytomegalovirus antigenemia in patients with autoimmune and non-autoimmune diseases in Beijing: A 10-year single hospital experience. PLoS One 2019;14:e0221793. [PMID: 31461496 DOI: 10.1371/journal.pone.0221793] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 Trier NH, Draborg AH, Sternbæk L, Troelsen L, Larsen JL, Jacobsen S, Houen G. EBNA1 IgM-Based Discrimination Between Rheumatoid Arthritis Patients, Systemic Lupus Erythematosus Patients and Healthy Controls. Antibodies (Basel) 2019;8:E35. [PMID: 31544841 DOI: 10.3390/antib8020035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]